Articles
-
1 day ago |
iam-media.com | Adam Houldsworth
Register for limited access Register to receive our newsletter and gain limited access to subscriber content. Register now Subscribe to unlock unlimited access Get news, unique commentary, expert analysis and essential resources from the IAM experts. Subscribe now Already have access? Login below
-
1 day ago |
iam-media.com | Adam Houldsworth
Register for limited access Register to receive our newsletter and gain limited access to subscriber content. Register now Subscribe to unlock unlimited access Get news, unique commentary, expert analysis and essential resources from the IAM experts. Subscribe now Already have access? Login below
-
2 days ago |
iam-media.com | Adam Houldsworth
Auto Injection Technologies lawsuits are the latest indication that patent assertion entities are targeting pharma and biotech spaces Register for limited access Register to receive our newsletter and gain limited access to subscriber content. Register now Subscribe to unlock unlimited access Get news, unique commentary, expert analysis and essential resources from the IAM experts. Subscribe now Already have access? Login below
-
1 week ago |
iam-media.com | Adam Houldsworth
Register for limited access Register to receive our newsletter and gain limited access to subscriber content. Register now Subscribe to unlock unlimited access Get news, unique commentary, expert analysis and essential resources from the IAM experts. Subscribe now Already have access? Login below
-
1 week ago |
iam-media.com | Adam Houldsworth
Patent leaders from Huawei, Oppo, Langbo and InterDigital emphasise recent shifts in the Chinese SEP landscape at IAM’s SEP Summit Asia Register for limited access Register to receive our newsletter and gain limited access to subscriber content. Register now Subscribe to unlock unlimited access Get news, unique commentary, expert analysis and essential resources from the IAM experts. Subscribe now Already have access? Login below
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →